Clinical Trials in Seattle

Showing 741-760 of 4,491 trials

Augmented Momentary Personal Ecological Risk Evaluation

NCT06704958

The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management. The main study aims are: * To co-design a prototype EMA suicide risk monitoring system with patients and health care provider input using Human Centered Design (HCD) methods. * To test the developed EMA protype with providers and their young adult patients aged 16-30 experiencing suicidality to determine if the EMA prototype is an acceptable and usable clinical tool. Young adult participants receiving care for active suicidal ideation will * Download and use the EMA prototype for a total of two months. * Complete 3 online surveys at 0, 1 and 2 months after enrolled in the study.

Suicidal IdeationSelf Harm

University of Washington50 participantsStarted Sep 2025

Seattle, Washington, United States

RECRUITINGPHASE3< 1 mile

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

NCT06898515

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

Acute Decompensated Heart Failure

Reprieve Cardiovascular, Inc400 participantsStarted Jul 2025

Irvine, California, United States • La Jolla, California, United States • Sacramento, California, United States +50 more locations

Augmented Momentary Personal Ecological Risk Evaluation

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Find Trials by Condition in Seattle

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) in JIA

Integrated Suicide Supports and Safety Planning for Youth

Preventing Medication-Related Problems in Care Transitions to Skilled Nursing Facilities

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study

A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain

Flexible-Dose Trial in Early Parkinson's Disease (PD)

Albumin Utilization in Adult Cardiac Surgical Patients: Retrospective

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)

A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9

A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care